Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Infectious Disease · Eumycetoma

Life After Treatment and Long-Term Care

At a Glance

After eumycetoma treatment, long-term follow-up matters because recurrence can appear months or years later. Regular clinical checks, specialist-directed ultrasound or MRI, prompt reporting of new lumps or drainage, rehabilitation, and emotional support help protect recovery.

Reaching the end of active treatment for eumycetoma is a significant milestone, but it is not the end of your journey. Because this fungus is exceptionally resilient and can hide deep within tissues, “survivorship” in eumycetoma involves long-term vigilance and a focus on regaining your quality of life [1][2].

The Risk of Recurrence

It is important to be realistic about the possibility of the infection returning, a situation known as recurrence. Even with excellent care, eumycetoma has a risk of coming back [3].

  • Recurrence Rates: Research shows that approximately 27% of patients experienced a recurrence in one large study after their initial surgery [2]. Some broader reviews suggest that in certain populations, long-term or recurrent disease can affect even more patients [1]. These figures apply to specific study populations, and your individual risk varies.
  • Risk Factors: Your risk of recurrence may be higher if your original infection was very large (greater than 10 cm), if you had the disease for more than 10 years before starting treatment, or if the infection was in an “extra-pedal” location (somewhere other than the foot) [2][4].
  • The “Silent” Phase: Recurrence doesn’t always happen right away. It can appear months or even years after you finish your medication [5].

Your Surveillance Schedule

Since recurrence can be subtle, you will need a long-term surveillance plan. This typically involves regular check-ups even when you feel perfectly fine [6]. There is no single evidence-based surveillance schedule for every patient.

  • Clinical Exams: Your doctor will perform physical exams to feel for new, firm masses or the reappearance of sinus tracts [7].
  • Imaging Follow-up: Ultrasound or MRI is often used when directed by your specialist based on original extent and symptoms [7][8]. Note that postoperative scarring or residual imaging abnormalities do not necessarily mean active infection.
  • What to Watch For: Do not wait for your next appointment if you notice a new lump, a “pin-prick” opening in the skin, a return of grain discharge, or a deep, dull ache in the bone [7][9].

Rehabilitation and Physical Health

Eumycetoma and its treatment—especially surgery—can change how your body moves.

  • Physical Therapy: If you had a wide local excision or a skin graft, you may have scar tissue that feels tight or limits your movement [10]. A physical therapist can help you with exercises to improve flexibility and strength [11].
  • Mobility Aids: For those who required amputation (which occurs in some advanced cases, ranging from 12% to 38% depending on the specific study population and disease severity), working with a prosthetic specialist is a vital part of recovery [4][1]. Many patients are able to return to walking and working with the help of modern mobility aids and rehabilitation [12].

Managing the Psychological Toll

The “not knowing” if the fungus will return can be mentally exhausting. This is sometimes called scanxiety—the stress and fear that build up before a follow-up imaging appointment.

  • The Burden of Monitoring: Eumycetoma can lead to feelings of social isolation or stigma due to scarring or disability [13][14]. In one systematic review, a significant impact on quality of life was frequently reported [1].
  • Support Systems: Acknowledging the psychological impact is a key part of healing. Discussing your fears with your care team, seeking counseling, or connecting with other survivors can help manage the long-term stress of monitoring a chronic condition [15][16]. Your resilience in completing treatment is a strength you can draw on as you move into this next phase of life.

Common questions in this guide

How often does eumycetoma come back after treatment?
Recurrence is possible even after successful treatment. One large study found that about 27% of patients had a recurrence after initial surgery, but the risk varies by lesion size, location, disease duration, and treatment history; recurrence may appear months or years later.
What changes could signal recurrent eumycetoma?
Contact your care team promptly if you notice a new firm lump, a tiny opening in the skin, renewed grain-like discharge, or a deep, dull ache in the bone. Do not wait for the next scheduled visit to report these changes.
What follow-up tests are used after eumycetoma treatment?
Your specialist may schedule regular physical examinations and may use ultrasound or MRI when your original disease extent or symptoms make imaging helpful. There is no single schedule for everyone, and scans should be interpreted in context because postoperative scarring or other residual abnormalities do not always mean active infection.
Can rehabilitation improve movement after eumycetoma surgery?
Yes. Physical therapy can address tight scar tissue and help restore flexibility and strength after wide local excision or a skin graft. If amputation was necessary, prosthetic and mobility rehabilitation can support walking and daily activities.
How can I manage fear or stress about eumycetoma returning?
Anxiety before follow-up scans and concerns about scarring or disability are understandable after eumycetoma treatment. Discuss these feelings with your care team, and consider counseling or a survivor support group to help manage stress and isolation.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on eumycotic mycetoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my initial lesion size and location, how often should I come back for clinical exams now that my treatment is finished?
  2. 2.When will my next ultrasound or MRI be scheduled to ensure no 'silent' fungal clusters are remaining?
  3. 3.Are there specific 'red flag' sensations, like deep bone aching, that I should report immediately between scheduled visits?
  4. 4.Can you refer me to a physical therapist or rehabilitation specialist to help me regain strength and mobility in my affected limb?
  5. 5.If I feel anxious about the infection returning, is there a patient support group or mental health resource you recommend?

References

References (16)
  1. 1

    Eumycetoma causative agents: A systematic review to inform the World Health Organization priority list of fungal pathogens.

    Clark JE, Kim HY, van de Sande WWJ, et al.

    Medical mycology 2024; (62(6)) doi:10.1093/mmy/myae044.

    PMID: 38935904
  2. 2

    Predictors of Post-operative Mycetoma Recurrence Using Machine-Learning Algorithms: The Mycetoma Research Center Experience.

    Wadal A, Elhassan TA, Zein HA, et al.

    PLoS neglected tropical diseases 2016; (10(10)):e0005007 doi:10.1371/journal.pntd.0005007.

    PMID: 27798643
  3. 3

    Mycetoma in the Sudan: an update from the Mycetoma Research Centre, University of Khartoum, Sudan.

    Fahal A, Mahgoub el S, El Hassan AM, Abdel-Rahman ME

    PLoS neglected tropical diseases 2015; (9(3)):e0003679 doi:10.1371/journal.pntd.0003679.

    PMID: 25816316
  4. 4

    Surgical management of eumycetoma: experience from Gezira Mycetoma Center, Sudan.

    Gismalla MDA, Ahmed GMA, MohamedAli MM, et al.

    Tropical medicine and health 2019; (47()):6 doi:10.1186/s41182-018-0129-2.

    PMID: 30675125
  5. 5

    [Recidives of Mycetoma after Amputation in Dakar (Senegal)].

    Sarr L, Dembélé B, Limam M, et al.

    Bulletin de la Societe de pathologie exotique (1990) 2019; (112(4)):195-201 doi:10.3166/bspe-2019-0103.

    PMID: 32003194
  6. 6

    Mycetoma management and clinical outcomes: the Mycetoma Research Center experience.

    Musa EA, Abdoon IH, Bakhiet SM, et al.

    Transactions of the Royal Society of Tropical Medicine and Hygiene 2023; (117(1)):12-21 doi:10.1093/trstmh/trac069.

    PMID: 35903002
  7. 7

    Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial.

    Fahal AH, Ahmed ES, Bakhiet SM, et al.

    The Lancet. Infectious diseases 2024; (24(11)):1254-1265 doi:10.1016/S1473-3099(24)00404-3.

    PMID: 39098321
  8. 8

    Mycetoma imaging: the best practice.

    Bahar ME, Bakheet OELH, Fahal AH

    Transactions of the Royal Society of Tropical Medicine and Hygiene 2021; (115(4)):387-396 doi:10.1093/trstmh/traa178.

    PMID: 33537774
  9. 9

    Painful mycetoma: a study to understand the risk factors in patients visiting the Mycetoma Research Centre (MRC) in Khartoum, Sudan.

    El-Amin SO, El-Amin RO, El-Sadig SM, et al.

    Transactions of the Royal Society of Tropical Medicine and Hygiene 2025; (119(2)):145-151 doi:10.1093/trstmh/trae093.

    PMID: 39611590
  10. 10

    Reconstructive surgery for mycetoma: Preliminary algorithm and a systematic review.

    Gismalla MDA, Bakhiet MY, Alshareef AM, et al.

    JPRAS open 2024; (40()):130-137 doi:10.1016/j.jpra.2024.02.002.

    PMID: 38854620
  11. 11

    Mycetoma: reviewing a neglected disease.

    Verma P, Jha A

    Clinical and experimental dermatology 2019; (44(2)):123-129 doi:10.1111/ced.13642.

    PMID: 29808607
  12. 12

    Advanced Eumycetoma of the Right Foot Resulting in Below-Knee Amputation in Somalia: A Case Report.

    Mahamud MA, Ahmed MM, Hassan SA, et al.

    International medical case reports journal 2026; (19()):633948 doi:10.2147/IMCRJ.S633948.

    PMID: 42808000
  13. 13

    Global sociodemographic, clinical, and epidemiological profiling of patients with mycetoma: A systematic review.

    Salah ME, Fearon Scales ML, Habib K, et al.

    PLoS neglected tropical diseases 2025; (19(8)):e0013217 doi:10.1371/journal.pntd.0013217.

    PMID: 40811735
  14. 14

    Mycetoma: a clinical dilemma in resource limited settings.

    Emmanuel P, Dumre SP, John S, et al.

    Annals of clinical microbiology and antimicrobials 2018; (17(1)):35 doi:10.1186/s12941-018-0287-4.

    PMID: 30097030
  15. 15

    Epidemiological observations and management challenges in extrapedal mycetoma: A three-decade review of 420 cases.

    Alhaj AAM, Ahmed ES, Hassan A, Fahal AH

    PLoS neglected tropical diseases 2024; (18(5)):e0011841 doi:10.1371/journal.pntd.0011841.

    PMID: 38728359
  16. 16

    A study of case management challenge for black grain eumycetoma during the ongoing war in Sudan.

    Siddig EE, Aradaib IE, Ahmed A

    Clinical case reports 2024; (12(9)):e9438 doi:10.1002/ccr3.9438.

    PMID: 39286753

This page is for informational purposes only and does not constitute medical advice. Your treating specialist should tailor eumycetoma surveillance, rehabilitation, and support to your medical history.